News and Trends 21 Feb 2018 FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s …type of monoclonal antibody known as a checkpoint inhibitor that targets the immune regulatory molecule PD-L1. The FDA approval for Imfinzi is the first authorization of a treatment for lung… February 21, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jun 2017 BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies BioNTech has reported a new technology that could overcome some of the most challenging issues of antibody production by encoding them into mRNA drugs. BioNTech, one of the most advanced… June 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 8 Oct 2019 Biotech Hubs: A Tale of Two Cities …founded the online antibody provider Abcam in 1998. Under his leadership, the company grew to be worth over €2B today. Having met with success, Milner became an angel investor in… October 8, 2019 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Sponsored by ACROBiosystems 3 Nov 2022 Impacting vaccine development: COVID-19 and its implications for the future of vaccines …the vaccination route and frequency, thus impacting the design of the immunization program. The breakthrough COVID-19 vaccines underwent the same checks and balances, with antibody detection methods of ELISA and… November 3, 2022 - 8 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Dec 2025 Eight of the biggest immunology and inflammation (I&I) deals in 2025 …commercial milestone payments. The two companies had previously collaborated in 2022 when AstraZeneca licensed Harbour BioMed’s preclinical bispecific antibody HBM7022. This time, the deal involved the discovery and development of next-generation multi-specific… December 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2018 Llama Antibodies Could Be the Key to Universal Flu Prevention …or different targets.” Indeed, the antibody developed by the group was built using four different llama antibodies, two targeting influenza A viruses and two targeting influenza B viruses to cover… November 1, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Mar 2017 What are the Best Countries to Recruit Biotech Talents in 2017? …Ablynx owns Nanobodies, smaller antibody fragments, and has a market cap of €800M. Biocartis develops molecular diagnostics for personalized medicine, with a market cap of €460M. TiGenix has stem cell… March 15, 2017 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored by Allucent 23 Sep 2025 The Netherlands: A strategic gateway for biotech clinical trials …she says. To ensure high-quality clinical trial performance, the CRO has built the “Allucent Centers of Expertise” or ACEs for specific complex therapeutic areas like oncology (including Antibody-Drug Conjugates, or… September 23, 2025 - 7 minutesmins - By Francina Agosti Share WhatsApp Twitter Linkedin Email
News and Trends 17 Dec 2018 Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease …with high triglycerides and higher cardiovascular risk. Staten’s lead candidate, licensed from Belgian biotech argenx, is a human antibody that targets ApoC3, reducing fatty molecules in the blood. Though the… December 17, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 25 Apr 2017 Novartis Negotiates its Way into the US Migraine Market …human monoclonal antibody, which targets the Calcitonin Gene-Related Peptide (CGRP) receptor. CGRP is thought to play a crucial role in mediating the incapacitating pain of migraine and increased blood levels… April 25, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022 Ophthalmology biopharma company Oculis combines with EBAC …treatment of inflammation and pain following cataract surgery, which would, if approved, potentially be the first once-a-day steroid for this indication. OCS-02 OCS-02 is a topical anti-TNF alpha monoclonal antibody… October 17, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jul 2024 From data to discovery: Five bioinformatics companies you should know in 2024 …the library, which is validated by next-generation sequencing. Last month, it reported the discovery of TB206-001, an antibody designed to improve cancer treatment, through its silicon platform. Twist has had… July 11, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email